4599 — StemRIM Share Price
0.000.00%
Last trade - 00:00- ¥26bn
- ¥18bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.94 | ||
| Price to Tang. Book | 2.94 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -22.38% | ||
| Return on Equity | -20.99% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Jul | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 2,100 | 1,400 | 22.98 | 2,350 | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
StemRIM Inc. is a Japan-based company mainly engaged in the regenerative medicine business. The Company is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.
Directors
- Kensuke Tomita CHM (70)
- Masatsune Okajima PRE (53)
- Takehiko Yamazaki EVP (51)
- Hirotada Nagai IND (45)
- Noriko Sawai IND (49)
- Last Annual
- July 31st, 2024
- Last Interim
- July 31st, 2024
- Incorporated
- October 30th, 2006
- Public Since
- August 9th, 2019
- No. of Employees
- 44
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 61,523,079
- Address
- 3F, Saito Bio-Incubator, 7-7-15, Saito, IBARAKI-SHI, 567-0085
- Web
- https://stemrim.com/
- Phone
- +81 726487152
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4599
Q1 2025 StemRIM Inc Earnings Release
Dividend For 4599.T - 0.0000 JPY
Q2 2025 StemRIM Inc Earnings Release
Similar to 4599
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the StemRIM share price?
As of Today at 23:55 UTC, shares in StemRIM are trading at ¥425. This share price information is delayed by 15 minutes.
How has the StemRIM share price performed this year?
Shares in StemRIM last closed at ¥425 and the price had moved by -45.37% over the past 365 days. In terms of relative price strength the StemRIM share price has underperformed the Nikkei 225 Index by -50.36% over the past year.
What are the analyst and broker recommendations for StemRIM?
The overall consensus recommendation for StemRIM is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the StemRIM dividend yield?
StemRIM does not currently pay a dividend.
Does StemRIM pay a dividend?
StemRIM does not currently pay a dividend.
When does StemRIM next pay dividends?
StemRIM does not currently pay a dividend.
How do I buy StemRIM shares?
To buy shares in StemRIM you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of StemRIM?
As of the previous close price of ¥425, shares in StemRIM had a market capitalisation of ¥26bn.
Where are StemRIM shares listed?
Here are the trading details for StemRIM:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4599
What kind of share is StemRIM?
Based on an overall assessment of its quality, value and momentum StemRIM is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a StemRIM share price forecast for 2024?
The analyst consensus target price for shares in StemRIM is ¥700. That is 64.71% above the last closing price of ¥425.
Analysts covering StemRIM currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the StemRIM share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like StemRIM. Over the past six months, its share price has underperformed the Nikkei 225 Index by -9.16%.
As of the last closing price of ¥425, shares in StemRIM were trading -13.21% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the StemRIM PE Ratio?
The StemRIM PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥425.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of StemRIM?
StemRIM's management team is headed by:
- Kensuke Tomita - CHM
- Masatsune Okajima - PRE
- Takehiko Yamazaki - EVP
- Hirotada Nagai - IND
- Noriko Sawai - IND